8-KFiled Jul 19, 8:00 PM ET

Healthcare Triangle, Inc. Reports Annual Meeting Vote Results (July 17, 2026)

$HCTI · Healthcare Triangle, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Healthcare Triangle, Inc. Reports Annual Meeting Vote Results (July 17, 2026)

What Happened
Healthcare Triangle, Inc. (HCTI) filed an 8-K on July 20, 2026 reporting the results of its virtual annual meeting held July 17, 2026. Shareholders elected four directors (Dave Rosa, Sujatha Ramesh, Ronald McClurg, Jainal Bhuiyan) to one-year terms, ratified SRCO Professional Corporation as the independent registered public accounting firm for fiscal 2026, and approved several proposals related to stock issuances and amending the 2020 Stock Incentive Plan.

Key Details

  • 20,386,046 shares were represented at the meeting (≈92.55% of 22,027,783 outstanding voting shares, including Series A Super Voting Preferred Stock).
  • Directors elected for terms expiring 2027: Dave Rosa; Sujatha Ramesh; Ronald McClurg; Jainal Bhuiyan (each approved by large majorities).
  • Approved amendment to the 2020 Stock Incentive Plan to allow automatic annual increases in shares reserved (first day of each fiscal year beginning 2026; greater of 2,000,000 shares, 20% of outstanding common stock, or administrator-determined amount; Plan ends Dec 31, 2030).
  • Shareholder approvals under Nasdaq rules: (a) future 20% issuances under Rule 5635(d); (b) issuance of 2,828,167 shares under a June 24, 2026 Settlement Agreement; (c) up to 11,869,397 shares for the Teyame transaction; (d) issuance in excess of the exchange cap under the ELOC Purchase Agreement; and (e) shares underlying OID Senior Secured Convertible Debentures (Nasdaq Rules 5635(a)/(b)/(d)).
  • Shareholders also approved the ability to adjourn the meeting to solicit additional proxies if needed.

Why It Matters
These votes authorize significant potential dilution via multiple approved issuances and an incentive-plan expansion, which can affect share count and ownership percentages. Ratifying the auditor and reelecting the board maintain continuity of management and oversight. Investors should note the specific issuance sizes (e.g., 2,828,167 shares settled, up to 11,869,397 for the Teyame deal) and the automatic plan increases when assessing future share supply and potential dilution.